Recurrent Acute Pancreatitis Clinical Trials

10 recruiting

Recurrent Acute Pancreatitis Trials at a Glance

10 actively recruiting trials for recurrent acute pancreatitis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Columbus, Pittsburgh, and Rochester. Lead sponsors running recurrent acute pancreatitis studies include Changhai Hospital, Cedars-Sinai Medical Center, and Anna Evans Phillips.

Browse recurrent acute pancreatitis trials by phase

Treatments under study

About Recurrent Acute Pancreatitis Clinical Trials

Looking for clinical trials for Recurrent Acute Pancreatitis? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Recurrent Acute Pancreatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Recurrent Acute Pancreatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

Chronic PancreatitisExocrine Pancreatic InsufficiencyRecurrent Acute Pancreatitis
Anna Evans Phillips80 enrolled2 locationsNCT07418593
Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center1,600 enrolled26 locationsNCT06651580
Recruiting
Phase 1Phase 2

Soy Tomato Juice to Improve Outcomes in Pancreatitis

Chronic PancreatitisRecurrent Acute Pancreatitis
Ohio State University35 enrolled1 locationNCT07447687
Recruiting
Early Phase 1

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

Chronic PancreatitisRecurrent Acute Pancreatitis
Cedars-Sinai Medical Center90 enrolled5 locationsNCT05771675
Recruiting
Phase 2

Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis

Smoking (Tobacco) AddictionPancreatitis, ChronicRecurrent Acute Pancreatitis+1 more
Mayo Clinic45 enrolled1 locationNCT07171112
Recruiting
Phase 2

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Recurrent Acute Pancreatitis
University of Alabama at Birmingham60 enrolled2 locationsNCT06253117
Recruiting
Not Applicable

Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis

Recurrent Acute Pancreatitis
Changhai Hospital158 enrolled1 locationNCT06364397
Recruiting

Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis

Recurrent Acute PancreatitisCohort Study
Changhai Hospital2,000 enrolled1 locationNCT06355206
Recruiting
Not Applicable

The Effect of Aspirin on Recurrent Acute Pancreatitis

PreventionRecurrent Acute PancreatitisAspirin
Air Force Military Medical University, China23 enrolled1 locationNCT06185621
Recruiting
Not Applicable

Preventing the Recurrence of Acute Pancreatitis by Alcohol and Smoking Cessation

Acute PancreatitisRecurrent Acute Pancreatitis
University of Pecs364 enrolled1 locationNCT04647097